1. Hydroxyeicosapentaenoic acids and epoxyeicosatetraenoic acids attenuate early occurrence of nonalcoholic fatty liver disease. (9th June 2017) Authors: Wang, Chunjiong; Liu, Wenli; Yao, Liu; Zhang, Xuejiao; Zhang, Xu; Ye, Chenji; Jiang, Hongfeng; He, Jinlong; Zhu, Yi; Ai, Ding Journal: British journal of pharmacology Issue: Volume 174:Number 14(2017) Page Start: 2358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Metabolic profiling of murine plasma reveals eicosapentaenoic acid metabolites protecting against endothelial activation and atherosclerosis. (5th September 2017) Authors: Liu, Yajin; Fang, Xuan; Zhang, Xu; Huang, Jing; He, Jinlong; Peng, Liyuan; Ye, Chenji; Wang, Yingmei; Xue, Fengxia; Ai, Ding; Li, Dan; Zhu, Yi Journal: British journal of pharmacology Issue: Volume 175:Number 8(2018) Page Start: 1190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗